REVBREVELATION BIOSCIENCES, INC.

Nasdaq revbiosciences.com


$ 2.16 $ 0.04 (1.87 %)    

Friday, 26-Apr-2024 14:55:27 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 2.18
$ 2.16
$ 2.13 x 100
$ 0.00 x 0
$ 2.16 - $ 2.16
$ 1.78 - $ 39.00
45,621
na
498,437
$ 1.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-22-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-22-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-14-2022 03-31-2022 10-Q
9 04-15-2022 12-31-2021 10-K
10 10-29-2021 09-30-2021 10-Q
11 08-23-2021 06-30-2021 10-Q
12 06-22-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 revelation-biosciences-q4-eps-833-beats-1377-estimate

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(8.33) per share which beat the analyst consensus estimate o...

 revelation-biosciences-presented-data-showing-pretreatment-with-gemini-improved-kidney-function-with-reduced-serum-blood-urea-nitrogen-and-creatinine-urine-c-reactive-protein-and-acute-kidney-injury-related-inflammation

Gemini is the company's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) for systemic administration....

 revelation-biosciences-commences-first-in-human-phase-1-clinical-study-of-gemini

 -Top-line data including safety, tolerability, and biomarker activity anticipated this summer--This Phase 1 clinical study dat...

 top-5-health-care-stocks-that-are-preparing-to-pump-in-february

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 why-skechers-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarte...

 why-meta-shares-are-trading-higher-by-over-16-here-are-20-stocks-moving-premarket

Shares of Meta Platforms, Inc. (NASDAQ: META) rose sharply in today’s pre-market trading as the company reported upbeat fourth-...

 dow-jumps-250-points-honeywell-issues-weak-forecast

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow t...

 why-ch-robinson-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-...

 crude-oil-gains-1-ism-manufacturing-pmi-tops-expectations

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.23...

 nasdaq-surges-100-points-us-jobless-claims-increase-to-224000

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the mark...

 why-nextracker-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket

Shares of Nextracker Inc. (NASDAQ: NXT) rose sharply during today’s pre-market trading after the company reported better-than-...

 why-amd-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD rep...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION